Finance

Lists
CLN:WSE
Celon Pharma SA
18,70 PLN
+0,11%
(+0,020) 1D
9 հոկ, 17:00:00 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
18,74 PLN
High
18,84 PLN
Low
18,68 PLN
Mkt. cap
1,01 մլրդ
Avg. vol.
15,19 հզր
Volume
4,06 հզր
P/E ratio
9,11
52-wk high
23,50 PLN
52-wk low
18,00 PLN
EPS
2,05 PLN
Shares outstanding
53,91 մլն
No. of employees
560
Open
18,74 PLN
High
18,84 PLN
Low
18,68 PLN
Mkt. cap
1,01 մլրդ
Avg. vol.
15,19 հզր
Volume
4,06 հզր
P/E ratio
9,11
52-wk high
23,50 PLN
52-wk low
18,00 PLN
EPS
2,05 PLN
Shares outstanding
53,91 մլն
No. of employees
560
News stories
From web sources and news partners
About Celon Pharma SA
CEO-
Employees560
Founded2002
Headquarters-
Sector-
Last report
16 սեպ, 2026 թ.
Fiscal period
Q2 2026
- / -
Revenue / Est. (PLN)
55,57 մլն / 60,50 մլն
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
71,13 մլն
66,67 մլն
65,26 մլն
55,57 մլն
Cost of goods sold
16,83 մլն
11,54 մլն
16,70 մլն
14,92 մլն
Cost of revenue
16,83 մլն
11,54 մլն
16,70 մլն
14,92 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,02 մլն
35,44 մլն
36,08 մլն
38,62 մլն
Operating expense
46,24 մլն
52,60 մլն
54,54 մլն
50,11 մլն
Total operating expenses
63,07 մլն
64,14 մլն
71,23 մլն
65,04 մլն
Operating income
8,06 մլն
2,53 մլն
-5,98 մլն
-9,46 մլն
Other non operating income
-30,00 հզր
-250,00 հզր
169,05 մլն
3,48 մլն
EBT including unusual items
-2,77 մլն
-6,57 մլն
160,34 մլն
-7,38 մլն
EBT excluding unusual items
-2,77 մլն
-6,57 մլն
160,34 մլն
-7,38 մլն
Income tax expense
-6,43 մլն
18,33 մլն
1,70 մլն
23,21 մլն
Effective tax rate
232,29%
-279,14%
1,06%
-314,48%
Other operating expenses
2,20 մլն
6,37 մլն
7,33 մլն
1,36 մլն
Net income
3,66 մլն
-24,90 մլն
158,64 մլն
-30,59 մլն
Net profit margin
5,15%
-37,35%
243,09%
-55,05%
Earnings per share
-
-
-
-
Interest and investment income
-
149,00 հզր
151,00 հզր
151,00 հզր
Interest expense
-
-341,00 հզր
-915,00 հզր
-1,55 մլն
Net interest expenses
-
-192,00 հզր
-764,00 հզր
-1,40 մլն
Depreciation and amortization charges
11,01 մլն
10,78 մլն
11,13 մլն
10,13 մլն
EBITDA
16,34 մլն
11,40 մլն
3,44 մլն
-748,00 հզր
Gain or loss from assets sale
-170,00 հզր
-2,91 մլն
-569,00 հզր
716,00 հզր
AI content may include mistakes. Learn more
Google Apps